Authors of CHEST’s newly developed clinical practice guidelines on venous thromboembolism (VTE) therapy and lung cancer screening will discuss the rationale behind some recommendations that might be considered controversial.

The ICU is among the settings with the highest rates of burnout among health care workers. On Monday morning, Curtis N. Sessler, MD, Master FCCP, will deliver the Presidential Honor Lecture about the importance of mitigating that longstanding problem.

“No one imagined the scope of the challenges on the system, including the need to creatively use nonclinical spaces for patient care,” said Sunita Sharma, MD.

Walk in a patient’s shoes and understand their challenges and concerns through Virtual Patient Tours (VPTs) available exclusively to CHEST 2021 registrants.

Jennifer Hunt, MD, is a best-selling author and certified executive coach, and she has extensive experience in coaching aspiring, emerging, and current high-achieving leaders.

Throughout the meeting, Program Co-Chairs Christopher Carroll, MD, FCCP, and David Zielinski, MD, FCCP—along with a rotating guest list of CHEST leaders—will be providing live insights, observations, and commentary.

Ryan Maves, MD, FCCP, will chair the session Viruses, Variants, Vaccines, and Virulence: The Present and Future of COVID-19 today. Presentations will cover the very latest developments in the pandemic.

The CHEST 2021 Opening Session this afternoon will include remarks from the current and incoming CHEST Presidents, an update from the CHEST Foundation President, and the highly anticipated Keynote Address.

Sara Pasha, MD, chairs a case-based session this afternoon featuring a panel of sleep apnea experts who will discuss some of the common clinical challenges encountered in the management of this disorder.

Watch demonstrations of percutaneous tracheostomy placement, echocardiography, and more, as expert faculty present skills that will translate into your real-life clinical practice.

Holly Keyt, MD, FCCP, chairs an interactive session looking at advances in cystic fibrosis treatment and currently available testing modalities and diagnostic algorithms for CF and CFTR-related disorders.